跳至主要内容
临床试验/EUCTR2009-012225-12-IT
EUCTR2009-012225-12-IT进行中(未招募)不适用

Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in head and neck cancer - 64-Cu-ATSM-CC-02/2009

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点目标入组 30 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. patients diagnosed with head and neck cancer (stage III and IV) scheduled for radiation therapy as elective treatment.
  • 2. age >18years
  • 3. signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. pregnancy 2. breastfeeding 3. healthy volunteers 4. age<18 5. patients in emergency situations 6. patients of un sound mind 7. patients who dont sign the informed consent

研究者

发起方
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

相似试验

进行中(未招募)
不适用
Role of 64Cu-ATSM PET/CT for the localization of hypoxic areas in uterine cervical cancer - 64Cu-ATSM-UTERO-01/2009Patients affected by uterine cervical cancer (sensitivity for localizing area of hypoxia within tumoral masses will be evaluated )MedDRA version: 9.1Level: LLTClassification code 10007493
EUCTR2009-011682-91-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI30
进行中(未招募)
1 期
se of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to be successfully treated to radiation therapy on the prostate bedcancer on the prostatic bedMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-004332-11-ITSPARKLE SR138
尚未招募
不适用
64CuATSM Positron Emission Tomography with Quantitative Susceptibility Mapping Magnetic Resonance Imaging as a Biomarker of Motor Neurone Diseasemotor neurone diseaseNeurological - Neurodegenerative diseases
ACTRN12623000067673Florey Institute of Neuroscience and Mental Health15
进行中(未招募)
1 期
64Cu-DOTATATE PET/CT-skanning to diagnose infection in the heart valvesInfective endocarditis
EUCTR2021-005501-27-DKRigshospitalet65
进行中(未招募)
1 期
Diagnostic-predictive value of copper-64 dichloride in bladder cancer patients eligible for chemotherapybladder cancer patients eligible for cisplatin chemotherapyMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2019-002534-37-ITENTE OSPEDALIERO OSPEDALI GALLIERA50